Combining CC-96191FC-SILENT with the parent CD33 mAb I07 did not restore the full cytolytic activity of CC-96191, suggesting that the co-engagement of NKG2D and CD16a on NK cells by the same molecule is important for anti-tumor activity. The gene discussed is CD33; the disease is neoplasm.